ATRI (Atrion Corp) Bozor qiymatining balans qiymatiga nisbati

Atrion Corp (ATRI) - korporativ logo

GURU.Markets grafigidagi Atrion Corporation (ATRI) uchun narxning buxgalteriya qiymatiga nisbati (P/B) kompaniyaning onkologiya uchun yuqori aniqlikdagi suyuqlik yetkazib berish tizimlari segmentidagi yetakchiligini tasdiqlaydi. 3.37 orqali kundalik narx harakati ushbu metrikaning joriy qiymatini ko'rsatib, o'zining AQSh zavodlarining barqarorligini va ishlab chiqarish sikllari ustidan to'liq nazoratni mustahkamlaydi. Biomeditisinaning gumanitar maqomi geosiyosiy risklarni minimallashtirib, har qanday sharoitda biznesning chidamliligini kafolatlaydi.

ATRI - Atrion Corporation Inc. Bozor qiymatining balans qiymatiga koeffitsiyenti 04.07.2022 - 31.08.2024 oraligʻida
Atrion Corp. tomonidan chiqariladigan mahsulotlar

Medtech nishasidagi shiddatli patent janglari fonida Atrion Corporation (ATRI) o'z aktivlaridan samarali foydalanishi lozim. Ushbu ko'rsatkich biznesning joriy bozor qiymatini uning sof aktivlari bilan solishtirib, kapitalning haddan tashqari qimmat yoki arzon baholanganligini aniqlaydi. Bozor qiymatining balans qiymatiga nisbati (market-to-book ratio) dagi o'zgarishlarni tahlil qilish orqali investor kompaniyaning moddiy aktivlariga nisbatan bozor premiumini aniqlay oladi. Ushbu nisbatning barqarorligi biznesning adolatli baholanganligini tasdiqlaydi, bu esa imkoniyatlarni boy berish xavfini bartaraf etgan holda, kirish nuqtasini o'z vaqtida aniqlash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Intuitive Surgical - Bozor kapitallashuvining balans qiymatiga nisbati|DHR (danaher.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati BDX|Kapitallashuvning sof aktivlarga nisbati STERIS PLC|West Pharmaceutical Services Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Baxter Healthcare (BAX)|MASI - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati stevanatogroup.com STVN|Bozor kapitallashuvining balans qiymatiga nisbati TFX (Teleflex)|MMSI - Balans qiymatiga nisbatan bozor kapitallashuvi|NVST (Envista Holdings Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|ICU Medical Inc. (ICUI) - Kapitallashuvning sof aktivlarga nisbati|XRAY (DENTSPLY SIRONA Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati LMAT|Bozor qiymatining balans qiymatiga nisbati AtriCure (ATRC)|Bozor qiymatining balans qiymatiga nisbati STAAR Surgical Co. STAA|Kapitallashuvning sof aktivlarga nisbati niagenbioscience.com|Balans qiymatiga nisbatan bozor qiymati ZimVie Corp ZIMV|Bozor kapitallashuvining balans qiymatiga nisbati ANGO (AngioDynamics, Inc.)|CERS: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Teknova|MGRM (Monogram Technologies Inc.) - Kapitallashuvning balans qiymatiga nisbati|STSS: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi InfuSystem Inc (INFU)|Kapitallashuvning sof aktivlarga nisbati Utah Medical Products|Bozor kapitallashuvining balans qiymatiga multiplikatori KRMD (korumedical.com)|Bozor qiymatining balans qiymatiga nisbati Nyxoah|MBOT - Balans qiymatiga nisbatan bozor qiymati|Pro-Dex Corp - Kapitallashuvning sof aktivlarga nisbati|ZTEK: Bozor kapitallashuvining balans qiymatiga nisbati|ELUT (Elutia Inc.) - Bozor qiymatining balans qiymatiga nisbati|milestonescientific.com (MLSS) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati NXGL (NEXGEL)|Bozor qiymatining balans qiymatiga koeffitsiyenti RVP|Bozor qiymatining balans qiymatiga nisbati Harvard Bioscience HBIO|Kapitallashuvning balans qiymatiga nisbati Femasys Corporation FEMY|Kapitallashuvning sof aktivlarga nisbati Meihua Medical Technologies Co., Ltd. (MHUA)|Predictive Oncology Inc - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati CJMB (Callan JMB Corp)|NURO - Balans qiymatiga nisbatan bozor kapitallashuvi